Bichen Pharmaceutical is a small-molecule tumor-targeted drug developer for the treatment of various malignant tumors and brain metastases.
Bichen Pharmaceutical is a small-molecule tumor-targeted drug developer for the treatment of various malignant tumors and brain metastases.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jan 4, 2022 | Series B | $30M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Tongde Capital | — | Series B |